Barbara Błaszczyk

1.5k total citations
31 papers, 1.2k citations indexed

About

Barbara Błaszczyk is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Barbara Błaszczyk has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 16 papers in Pediatrics, Perinatology and Child Health and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Barbara Błaszczyk's work include Epilepsy research and treatment (17 papers), Pharmacological Effects and Toxicity Studies (15 papers) and Neuroscience and Neuropharmacology Research (9 papers). Barbara Błaszczyk is often cited by papers focused on Epilepsy research and treatment (17 papers), Pharmacological Effects and Toxicity Studies (15 papers) and Neuroscience and Neuropharmacology Research (9 papers). Barbara Błaszczyk collaborates with scholars based in Poland, United States and France. Barbara Błaszczyk's co-authors include Stanisław J. Czuczwar, Piotr Czapiński, Philippe Ryvlin, Konrad J. Werhahn, Martin Johnson, Sarah Lu, Władysław Lasoń, Barbara Miziak, Waldemar Brola and Matilde Leonardi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Stroke and International Journal of Molecular Sciences.

In The Last Decade

Barbara Błaszczyk

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Błaszczyk Poland 15 596 485 411 177 157 31 1.2k
José H. Woodhead United States 14 566 0.9× 351 0.7× 533 1.3× 282 1.6× 100 0.6× 19 982
Francesca Scicchitano Italy 15 281 0.5× 153 0.3× 319 0.8× 198 1.1× 166 1.1× 21 947
Alan W.C. Yuen United Kingdom 18 909 1.5× 771 1.6× 347 0.8× 148 0.8× 48 0.3× 28 1.4k
A. W. Peck United Kingdom 24 885 1.5× 802 1.7× 379 0.9× 182 1.0× 248 1.6× 41 1.9k
Stefan Schwabe United States 18 986 1.7× 569 1.2× 182 0.4× 91 0.5× 144 0.9× 40 1.3k
Amitabh Dash Japan 12 342 0.6× 204 0.4× 151 0.4× 110 0.6× 123 0.8× 31 673
Cristiana Gassmann-Mayer United States 16 1.2k 1.9× 318 0.7× 126 0.3× 55 0.3× 173 1.1× 16 1.6k
AF Cohen Netherlands 17 253 0.4× 142 0.3× 373 0.9× 170 1.0× 294 1.9× 31 1.0k
Steve Chung United States 23 1.5k 2.5× 1.2k 2.4× 665 1.6× 96 0.5× 192 1.2× 58 1.9k
A A Miller United Kingdom 13 694 1.2× 522 1.1× 549 1.3× 215 1.2× 72 0.5× 25 1.1k

Countries citing papers authored by Barbara Błaszczyk

Since Specialization
Citations

This map shows the geographic impact of Barbara Błaszczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Błaszczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Błaszczyk more than expected).

Fields of papers citing papers by Barbara Błaszczyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Błaszczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Błaszczyk. The network helps show where Barbara Błaszczyk may publish in the future.

Co-authorship network of co-authors of Barbara Błaszczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Błaszczyk. A scholar is included among the top collaborators of Barbara Błaszczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Błaszczyk. Barbara Błaszczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Błaszczyk, Barbara, Stanisław J. Czuczwar, & Barbara Miziak. (2024). Cenobamate, a New Promising Antiseizure Medication: Experimental and Clinical Aspects. International Journal of Molecular Sciences. 25(23). 13014–13014. 1 indexed citations
2.
Miziak, Barbara, Barbara Błaszczyk, Magdalena Chrościńska–Krawczyk, & Stanisław J. Czuczwar. (2023). Caffeine and Its Interactions with Antiseizure Medications—Is There a Correlation between Preclinical and Clinical Data?. International Journal of Molecular Sciences. 24(24). 17569–17569. 3 indexed citations
3.
Jarosławski, Szymon, et al.. (2020). Health-related quality of life of patients after ischaemic stroke treated in a provincial hospital in Poland. SHILAP Revista de lepidopterología. 8(1). 1775933–1775933. 8 indexed citations
4.
Błaszczyk, Barbara, et al.. (2018). A viewpoint on rational and irrational fixed-drug combinations. Expert Review of Clinical Pharmacology. 11(8). 761–771. 32 indexed citations
5.
Błaszczyk, Barbara & Stanisław J. Czuczwar. (2016). Epilepsy coexisting with depression. Pharmacological Reports. 68(5). 1084–1092. 89 indexed citations
6.
Błaszczyk, Barbara. (2015). Drug-resistant epilepsy from the clinical point of view. Pharmacological Reports. 67. 5–5. 1 indexed citations
7.
Owczarek, Krzysztof, et al.. (2015). Declared satisfaction with sexual life and the quality of life in patients with epilepsy. 1 indexed citations
8.
Błaszczyk, Barbara, Władysław Lasoń, & Stanisław J. Czuczwar. (2014). Antiepileptic drugs and adverse skin reactions: An update. Pharmacological Reports. 67(3). 426–434. 84 indexed citations
9.
Miziak, Barbara, et al.. (2014). The problem of osteoporosis in epileptic patients taking antiepileptic drugs. Expert Opinion on Drug Safety. 13(7). 935–946. 40 indexed citations
10.
Miziak, Barbara, et al.. (2013). Novel approaches to anticonvulsant drug discovery. Expert Opinion on Drug Discovery. 8(11). 1415–1427. 12 indexed citations
11.
Błaszczyk, Barbara, Monika Szpringer, Stanisław J. Czuczwar, & Władysław Lasoń. (2013). Single centre 20 year survey of antiepileptic drug-induced hypersensitivity reactions. Pharmacological Reports. 65(2). 399–409. 27 indexed citations
12.
Brola, Waldemar, et al.. (2012). Quality of life in Parkinson's disease.. PubMed. 5(4). 375–81. 87 indexed citations
13.
Błaszczyk, Barbara. (2010). Epilepsy and allergy. Pharmacological Reports. 62(2). 429–430. 1 indexed citations
14.
Chrościńska–Krawczyk, Magdalena, et al.. (2007). [Caffeine and antiepileptic drugs: experimental and clinical data].. PubMed. 64(11). 965–7. 13 indexed citations
15.
Błaszczyk, Barbara, et al.. (2006). Non-epilepsy uses of antiepilepsy drugs.. PubMed. 58(1). 1–12. 37 indexed citations
16.
Czapiński, Piotr, Barbara Błaszczyk, & Stanisław J. Czuczwar. (2005). Mechanisms of Action of Antiepileptic Drugs. Current Topics in Medicinal Chemistry. 5(1). 3–14. 296 indexed citations
17.
Nowak, Stanisław, et al.. (2003). Neuroprotective effects of antiepileptic drugs.. PubMed. 54(6). 557–66. 60 indexed citations
18.
Radek, A, et al.. (2001). [Stereotactic biopsy and brachytherapy in the diagnostics and treatment of brain tumors--preliminary report].. PubMed. 35 Suppl 5. 5–11. 1 indexed citations
19.
Błaszczyk, Barbara, et al.. (1985). [Analysis of clinico-social features of epilepsy].. PubMed. 19(3). 199–204. 1 indexed citations
20.
Gryglewski, Ryszard J., Sebastian Nowak, E Kostka-Trąbka, et al.. (1983). Treatment of ischaemic stroke with prostacyclin.. Stroke. 14(2). 197–202. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026